Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 14/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.64 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.57 |
| ▸ | DCTPP1 | Q9H773 | 4/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1850001 | 0.94 | MAPT (0.66) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL2762728 | 0.92 | HTR6 (0.60) | MAPTALDH1A1NPSR1CYP3A4CYP2C9 | |
| SCHEMBL1840597 | 0.92 | MAPT (0.66) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1843164 | 0.90 | MAPT (0.68) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL30360208 | 0.90 | MAPT (0.68) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1844190 | 0.89 | MAPT (0.66) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1844702 | 0.89 | MAPT (0.66) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1843205 | 0.86 | MAPT (0.82) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1841490 | 0.86 | MAPT (0.75) | MAPTALDH1A1NPSR1SIRT6CYP3A4 | |
| SCHEMBL1846585 | 0.86 | MAPT (0.71) | MAPTALDH1A1NPSR1SIRT6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2320897-A1 | COMPOSITIONS AND METHODS OF TREATING AMYLOID DISEASE | Treventis Corporation (US) | 2011-05-18 | — | — | EP | claimed |
| WO-2010025375-A1 | COMPOSITIONS AND METHODS OF TREATING AMYLOID DISEASE | TREVENTIS CORPORATION (US) | 2010-03-04 | — | — | WO | claimed |